Duquesne
XENE · Medicine & biotech

Xenon Pharmaceuticals

Develops drugs for epilepsy and depression.
No change
Duquesne owns 238,600 shares of Xenon Pharmaceuticals, worth about $14 million. That’s less than $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
238,600
Jun 30
238,600

The numbers

Shares they own
238,600
Value on Jun 30, 2026
$14,402,000
about $14 million
Share of their money
0.3%
less than $1 of every $100 · 58th of 85
Price per share on Jun 30
$60.36
Kind
Shares
Also owned by
No other fund we follow
More about Xenon Pharmaceuticals
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works